North American Education And Healthcare Deals Will Drive Future Success

Published
12 Nov 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
€67.89
22.9% undervalued intrinsic discount
14 Aug
€52.35
Loading
1Y
-39.9%
7D
0.9%

Author's Valuation

€67.9

22.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 8.60%

Shared on23 Apr 25
Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.54%

AnalystConsensusTarget has increased revenue growth from 3.9% to 4.4%.

Shared on02 Apr 25
Fair value Decreased 5.02%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 13%

AnalystConsensusTarget has decreased revenue growth from 5.2% to 4.1%.

Shared on19 Mar 25
Fair value Decreased 0.065%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 26%

AnalystConsensusTarget has increased revenue growth from 3.8% to 5.4%, increased future PE multiple from 16.0x to 18.1x and decreased shares outstanding growth rate from -0.0% to -0.0%.